PATENT CLAIM ANALYSIS

Application Number: 16093376
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "342000"]

Abstract:
Disclosed is a compound for treating fibrosis-related diseases, and specifically disclosed are the compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Claim (Index 1):
A compound shown in formula (I), a pharmaceutically acceptable salt and a tautomer thereof, wherein, X is selected from O, S, and N(R); R 2  is selected from F, Cl, Br, I, OH, NH 2 , CN, NO 2 , COOH, or selected from the group consisting of C 1-6  alkyl and C 1-6  heteroalkyl, the C 1-6  alkyl and C 1-6  heteroalkyl are optionally substituted with 1, 2 or 3 of R; R 3  is selected from H, or selected from the group consisting of C 1-6  alkyl and C 1-6  heteroalkyl, the C 1-6  alkyl and C 1-6  heteroalkyl are optionally substituted with 1, 2 or 3 of R; R 4  is selected from F, Cl, Br, I, OH, NH 2 , NO 2 , CN, COOH, or selected from the group consisting of C 1-6  alkyl and C 1-6  heteroalkyl, the C 1-6  alkyl and C 1-6  heteroalkyl are optionally substituted with 1, 2 or 3 of R; Ring A is selected from 5-10-membered aryl and 5-10-membered heteroaryl; m is selected from 0, 1 or 2; n is selected from 0, 1 or 2; m and n are not 0 at the same time; p is selected from 0, 1, 2 or 3; R is selected from H, F, Cl, Br, I, OH, CN, NH 2 , COOH, C(\u2550O)NH 2 , or selected from the group consisting of C 1-8  alkyl, C 1-8  heteroalkyl, C 3-6  cycloalkyl, 3 to 6-membered heterocycloalkyl and C 3-6  cycloalkyl-C 1-3  alkyl-, the C 1-8  alkyl, C 1-8  heteroalkyl, C 3-6  cycloalkyl, 3 to 6-membered heterocycloalkyl and C 3-6  cycloalkyl-C 1-3  alkyl- are optionally substituted with 1, 2 or 3 of R\u2032; R\u2032 is selected from F, Cl, Br, I, OH, CN, NH 2 , COOH, Me, Et, CF 3 , CHF 2 , CH 2 F, NHCH 3 , N(CH 3 ) 2 ; \u201chetero\u201d means hetero atom or hetero atom group, which is selected from the group consisting of C(\u2550O)N(R)\u2014, \u2014N(R)\u2014, \u2014C(\u2550NR)\u2014, \u2014S(\u2550O) 2 N(R)\u2014, \u2014S(\u2550O)N(R), \u2014O\u2014, \u2014S\u2014, \u2550O, \u2550S, \u2550O\u2014N\u2550, \u2014C(\u2550O)O\u2014, \u2014C(\u2550O)\u2014, \u2014C(\u2550S)\u2014, \u2014S(\u2550O)\u2014, \u2014S(\u2550O) 2 \u2014 and \u2014N(R)C(\u2550O)N(R)\u2014; In any case above, the number of hetero atom or hetero group is independently selected from 1, 2 or 3, respectively.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16325626', '16326976', '16066852', '16096848', '15750704']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8400214511884002
- 35 USC 102 Novelty (BERT): 0.5550134788182247
- Combined Prediction Score: 0.8115206539513827
- Mean Citation Score: 391.3555060000001
- Max Citation Score: 429.8432
- Similarity Product: 368.1085242412568

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test